secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apogee Therapeutics, Inc. (APGE)
CIK:        0001974640
Form:       8-K
Filed at:   2026-04-24T23:59:59+00:00
Accession:  0001193125-26-177288
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Two directors resign from Apogee board; board shrinks from 9 to 7
-----------------------------------------------------------------

- Andrew Gottesdiener, M.D. and Peter Harwin notified Board of resignations effective May 11, 2026.
- Resignations are not due to any disagreement with Company's operations, policies or practices.
- Board size will be reduced from nine to seven directors effective May 11, 2026.
- No replacements announced; CEO Michael Henderson remains in role.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1974640/000119312526177288/0001193125-26-177288-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1974640/000119312526177288/apge-20260421.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-177288

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer